Treatment of Chronic Fatigue/Myalgic Encephalitis Syndrome: Blocking the IL-1 Component to the Inflammatory Response Is Ineffective

    loading  Checking for direct PDF access through Ovid

Abstract

Blockade of IL-1 activity with anakinra failed to reduce fatigue in patients with chronic fatigue syndrome.

Related Topics

    loading  Loading Related Articles